Denosumab versus zoledronic acid for preventing symptomatic skeletal events in Asian postmenopausal women with oestrogen-receptor-positive advanced breast cancer: an outcome analyses with a mean follow-up of 3  years

The purpose of this study was to evaluate the efficacy of denosumab or zoledronic acid (ZA) using symptomatic skeletal events (SSEs) as the primary endpoint in Asian postmenopausal women with oestrogen-recepto...

Source: BMC Musculoskeletal Disorders - November 30, 2018 Category: Orthopaedics Authors: Chi Zhang, Fan Zhang, Guanzhao Liang, Xianshang Zeng, Weiguang Yu, Zhidao Jiang, Jie Ma, Mingdong Zhao, Min Xiong, Keke Gui, Fenglai Yuan and Weiping Ji Tags: Research article Source Type: research